Evidence map›Paper›PMID 30538046›Full record

ArticleBiochemical and biophysical research communications2019

TGFβ2-induced tenogenesis impacts cadherin and connexin cell-cell junction proteins in mesenchymal stem cells.

Sophia K Theodossiou, John Tokle, Nathan R Schiele

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. The LINC Complex Regulates Tendon Elastic Modulus, Collagen Crimp, and Lateral Expansion During Early Postnatal Development.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Growth factors in the treatment of Achilles tendon injury.Frontiers in bioengineering and biotechnology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Mechanotransduction of stem cells for tendon repair.World journal of stem cells · 2020
    Review
  18. Review
  19. Using tools in mechanobiology to repair tendons.Current tissue microenvironment reports · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sophia K TheodossiouBiological Engineering, 875 Perimeter Dr. MS 0904, University of Idaho, Moscow, ID, 83844, USA. Electronic address: theo4146@vandals.uidaho.edu.
John TokleBiological Sciences, 875 Perimeter Dr. MS 3051, University of Idaho, Moscow, ID, 83844, USA. Electronic address: tokl6544@vandals.uidaho.edu.
Nathan R SchieleBiological Engineering, 875 Perimeter Dr. MS 0904, University of Idaho, Moscow, ID, 83844, USA. Electronic address: nrschiele@uidaho.edu.
University of Idaho · US

Funding

Women's health: interplay of maternal diet and key demographics on neurological health in the rural frontier and remote WestP20GM103408 · NIGMS · UNIVERSITY OF IDAHO · PI Scott A Minnich · 2012 to 2026
$59.8M
NIGMS NIH HHS P20 GM103408
6 · The paper itself

Abstract

Tenogenic differentiation of stem cells is needed for tendon tissue engineering approaches. A current challenge is the limited information on the cellular-level changes during tenogenic induction. Tendon cells in embryonic and adult tendons possess an array of cell-cell junction proteins that include cadherins and connexins, but how these proteins are impacted by tenogenic differentiation is unknown. Our objective was to explore how tenogenic induction of mesenchymal stem cells (MSCs) using the transforming growth factor (TGF)β2 impacted protein markers of tendon differentiation and protein levels of N-cadherin, cadherin-11 and connexin-43. MSCs were treated with TGFβ2 for 21 days. At 3 days, TGFβ2-treated MSCs developed a fibroblastic morphology and significantly decreased levels of N-cadherin protein, which were maintained through 21 days. Similar decreases in protein levels were found for cadherin-11. Connexin-43 protein levels significantly increased at 3 days, but then decreased below control levels, though not significantly. Protein levels of scleraxis and tenomodulin were significantly increased at day 14 and 21, respectively. Taken together, our results indicate that TGFβ2 is an inducer of tendon marker proteins (scleraxis and tenomodulin) in MSCs and that tenogenesis alters the protein levels of N-cadherin, cadherin-11 and connexin-43. These findings suggest a role for connexin-43 early in tenogenesis, and show that early-onset and sustained decreases in N-cadherin and cadherin-11 may be novel markers of tenogenesis in MSCs.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCadherinsCells, CulturedConnexin 43FibroblastsMembrane ProteinsMesenchymal Stem CellsMiceTransforming Growth Factor beta2Basic Helix-Loop-Helix ProteinsCadherinsCdh2 protein, mouseConnexin 43GJA1 protein, mouseMembrane Proteinsosteoblast cadherinScx protein, mouseTGFB2 protein, humanTnmd protein, mouseTransforming Growth Factor beta2CadherinConnexinStem cellsTendonTenogenesisTissue engineering

Identifiers

PMID30538046
PMCPMC6394875
OpenAlexW2904519518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.